In addition, treatment of NPC cells with a PI3K inhibitor LY294002 results in inhibition of Akt activation, thereby hindering cell proliferation and inducing cell apoptosis [55]. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.